Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Vincenti

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell AnalysesMeixue Duan, Doan C Nguyen, Chester J Joyner, et al.
Cell Reports|June 25, 2023
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analysesMeixue Duan, Doan C Nguyen, Chester J Joyner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2019
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM studyStefan P Berger, Claudia Sommerer, Oliver Witzke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2024
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidatesAlba Torija, Marie Matignon, Flavio Vincenti, et al.
Transplantation Direct|January 22, 2026
Combined Anti-CD20/Anti-CD38 Therapy in Posttransplant Focal Segmental Glomerulosclerosis Recurrence: A Retrospective, International, Multicenter StudyPaolo Cravedi, Umberto Maggiore, Gabriele Mortari, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2014
Role of podocyte B7-1 in diabetic nephropathyPaolo Fiorina, Andrea Vergani, Roberto Bassi, et al.
Journal of the American Society of Nephrology : JASN|October 4, 2022
Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 TrialDonald E Hricik, Brian Armstrong, Tarek Alhamad, et al.
BMJ (Clinical Research Ed.)|May 31, 2023
Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation studyMarc Raynaud, Solaf Al-Awadhi, Ivana Juric, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell AnalysesMeixue Duan, Doan C Nguyen, Chester J Joyner, et al.
Cell Reports|June 25, 2023
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analysesMeixue Duan, Doan C Nguyen, Chester J Joyner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2019
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM studyStefan P Berger, Claudia Sommerer, Oliver Witzke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2024
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidatesAlba Torija, Marie Matignon, Flavio Vincenti, et al.
Transplantation Direct|January 22, 2026
Combined Anti-CD20/Anti-CD38 Therapy in Posttransplant Focal Segmental Glomerulosclerosis Recurrence: A Retrospective, International, Multicenter StudyPaolo Cravedi, Umberto Maggiore, Gabriele Mortari, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2014
Role of podocyte B7-1 in diabetic nephropathyPaolo Fiorina, Andrea Vergani, Roberto Bassi, et al.
Journal of the American Society of Nephrology : JASN|October 4, 2022
Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 TrialDonald E Hricik, Brian Armstrong, Tarek Alhamad, et al.
BMJ (Clinical Research Ed.)|May 31, 2023
Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation studyMarc Raynaud, Solaf Al-Awadhi, Ivana Juric, et al.
Pageof 12